Summary

Protein Biomarker Development, Molecular Diagnostics, Precision Medicine, bioanalytical platforms

Description

Proteas Bioanalytics Inc., develops innovative proteomics platforms to detect human diseases at their earliest stage, before the onset of symptoms, from a single drop of blood. Our advanced technologies will also provide objective guidance regarding treatment options and efficacy. We intend to dramatically reshape early diagnosis and treatment across multiple diseases.Business: We are both a platform and disease-specific biosignature assay development and implementation company. Our core bioanalysis technology can be partnered across indications to pharma and biotech companies, while our internal biomarker platforms will be developed for high unmet needs in the clinical arena.

Special details

Mission: The development of transformative precision medicine platforms enabling unpresented analytical performance from a drop of blood. To advance our technology objectives, we have built a world-class team of board members, laboratory scientists, business, and FDA-regulatory advisors with extensive experience and proven track record across research and development, partnering, biology, pharmacology, analytical chemistry, nanotechnology, mathematics, and artificial intelligence.

Profile

  • Incorporated in
    California
  • Established since
    2020
  • Main/Branch
    Branch

Address

Contact